Corteria Pharmaceuticals
Corteria Pharmaceuticals is an interceptive therapies for heart failure subpopulations founded in 2021.
4
Funding Rounds
$153.0m
Money raised
Overview
Corteria Pharmaceuticals is an interceptive therapies for heart failure subpopulations founded in 2021.
- Website:
- Headquarters: Paris
- Social accounts: linkedin
Funding
Funding series
Funding Series Analysis
The company Corteria Pharmaceuticals has raised a total of $153m in funding over 4 rounds.
Key Insights:
- Corteria Pharmaceuticals September 2023 Series A Funding Round: $70m
- Corteria Pharmaceuticals September 2023 Series A Funding Round: $70m
- Corteria Pharmaceuticals December 2021 Seed Funding Round: $13m
Corteria Pharmaceuticals September 2023 Series A Funding Round
$70m
Corteria Pharmaceuticals September 2023 Series A Funding Round
$70m
Corteria Pharmaceuticals December 2021 Seed Funding Round
$13m
Industries
Corteria Pharmaceuticals is active in the following industries: